No significant difference was observed in age, BPH duration, chronic disease, presurgical prostate size, PSA, QoL, Qmax, PVR, number of resurgeries, and the incidence of remedication between the two groups (Table 3). This evidence concerns the gene KLK3 and benign prostatic hyperplasia.